Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients.
Alegre A, Aguado B, Giraldo P, Ríos E, Cánovas A, Ibáñez Á, Castillo I, Hernández MT, Oriol A, Palomera L, Rodríguez JN, García FL, Calvo JM, Martínez-Chamorro C, de la Serna J, Lahuerta JJ. Alegre A, et al. Among authors: castillo i. Int J Hematol. 2011 Mar;93(3):351-360. doi: 10.1007/s12185-011-0785-z. Epub 2011 Mar 1. Int J Hematol. 2011. PMID: 21360065 Clinical Trial.
Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
Pérez R, Durán MS, Mayans J, Soler A, Castillo I, Jurado M, Ribas P, Menchaca Echevarria MC, Hernandez MT, Lopez Garcia-Carreño MD, Echeveste Gutierrez A, Bailen Garcia A, Lopez S, Baquero J, Ramirez G. Pérez R, et al. Among authors: castillo i. Eur J Haematol. 2016 Apr;96(4):417-24. doi: 10.1111/ejh.12611. Epub 2015 Nov 1. Eur J Haematol. 2016. PMID: 26190662
Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).
Benet I, Prosper BF, Marugan I, Lluch A, Arbona C, Castillo I, Solano C, Garcia-Conde J. Benet I, et al. Among authors: castillo i. Bone Marrow Transplant. 1999 Jun;23(11):1101-7. doi: 10.1038/sj.bmt.1701774. Bone Marrow Transplant. 1999. PMID: 10382948 Clinical Trial.
443 results